FDA Approved: NEUPRO — Original Application (UCB, Inc.)

View source ↗

Summary

FDA approved NEUPRO (rotigotine) transdermal patch from UCB, Inc. under NDA021829 for the treatment of Parkinson's disease and restless legs syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Neupro (rotigotine)

Snippet

ORIG AP for NEUPRO (ROTIGOTINE)